Trial Profile
Does Glucagon-Like Polypeptide 1 improve vascular function and inflammation?
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Aspirin
- Indications Embolism and thrombosis; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms GLP-1ADDS
- 03 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2013 Accrual to date is 47% according to United Kingdom Clinical Research Network.
- 24 Oct 2013 Accrual to date is 43% according to United Kingdom Clinical Research Network.